Deutsche Bank’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-873
| Closed | -$2K | – | 4412 |
|
|
2021
Q2 | $2K | Buy |
+873
| New | +$2K | ﹤0.01% | 4355 |
|
|
2017
Q3 | – | Sell |
-33,057
| Closed | -$276K | – | 4456 |
|
|
2017
Q2 | $276K | Sell |
33,057
-7,562
| -19% | -$63.1K | ﹤0.01% | 3636 |
|
|
2017
Q1 | $552K | Buy |
40,619
+9,519
| +31% | +$129K | ﹤0.01% | 2955 |
|
|
2016
Q4 | $138K | Hold |
31,100
| – | – | ﹤0.01% | 3716 |
|
|
2016
Q3 | $177K | Sell |
31,100
-8
| -0% | -$46 | ﹤0.01% | 3562 |
|
|
2016
Q2 | $199K | Sell |
31,108
-20
| -0.1% | -$128 | ﹤0.01% | 3652 |
|
|
2016
Q1 | $261K | Sell |
31,128
-493
| -2% | -$4.13K | ﹤0.01% | 3436 |
|
|
2015
Q4 | $322K | Buy |
31,621
+30,541
| +2,828% | +$311K | ﹤0.01% | 3380 |
|
|
2015
Q3 | $12K | Buy |
+1,080
| New | +$12K | ﹤0.01% | 4472 |
|
|
2015
Q1 | – | Sell |
-148
| Closed | -$2K | – | 5081 |
|
|
2014
Q4 | $2K | Sell |
148
-26,211
| -99% | -$354K | ﹤0.01% | 5343 |
|
|
2014
Q3 | $637K | Buy |
+26,359
| New | +$637K | ﹤0.01% | 3246 |
|